stars 1 stars 2 stars 3

Vivani Medical is a clinical stage developer of long-term pharmaceutical implants aimed at revolutionizing the treatment of patients with chronic diseases. Leveraging its proprietary NanoPortal™ platform, Vivani’s portfolio of tiny, subdermal drug implants address medication non-adherence by providing steady levels of medication over a target duration of six months or longer. Vivani is initially focused on developing a miniature, long-term GLP-1 implants for the treatment of obesity and chronic weight management: NPM-139 (semaglutide). In addition, the company is developing NPM-133, a semaglutide implant for the treatment of type 2 diabetes.

Vivani Questions

The Vivani annual revenue was $26.6 million in 2026.

Adam Mendelsohn is the CEO of Vivani.

20 people are employed at Vivani.

Vivani is based in Alameda, California.

Top Vivani Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users